CKR-9 Antibodies

Santa Cruz Biotechnology provides a broad selection of CKR-9 monoclonal antibodies for research applications. CKR-9 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CKR-9, also known as chemokine receptor 9, plays a crucial role in the immune response by mediating the migration of immune cells to sites of inflammation. The involvement of CKR-9 in various physiological and pathological processes makes it a significant target for research in immunology and cancer biology. Understanding CKR-9 function can provide insights into therapeutic strategies for diseases associated with immune dysregulation. Researchers can utilize CKR-9 monoclonal antibodies to investigate cellular signaling pathways and protein interactions. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of CKR-9 expression patterns. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing immunology and cancer research through reliable and specific detection of CKR-9.